A nurse is caring for a client who is postpartum and received methylergonovine (methergine). Which of the following findings indicates that the medication was effective?
A.
Report of absent breast pain
B.
Increase in lochia
C.
Increase in blood pressure
D.
Fundus firm to palpation
The correct answer and Explanation is :
The correct answer is D. Fundus firm to palpation.
Explanation:
Methylergonovine (Methergine) is a medication used to prevent or control postpartum hemorrhage by stimulating uterine contractions. It works by causing the uterus to contract more effectively, which helps to decrease bleeding by compressing the uterine blood vessels.
When assessing the effectiveness of Methylergonovine, one of the key indicators is whether the fundus (the upper part of the uterus) is firm to palpation. A firm fundus indicates that the uterus is contracting properly and has returned to its normal size and tone, which helps to reduce postpartum bleeding. This is a direct result of the medication’s action in stimulating uterine contractions.
Here’s a breakdown of the other options and why they are not correct:
- A. Report of absent breast pain: Methylergonovine is not primarily used to address breast pain. It is intended to manage uterine bleeding. The absence of breast pain is not a relevant indicator of the medication’s effectiveness in managing postpartum bleeding.
- B. Increase in lochia: Lochia is the postpartum vaginal discharge that occurs after childbirth. An increase in lochia could indicate excessive bleeding rather than effective management. A firm fundus, not the amount of lochia, is the primary indicator of effective uterine contraction.
- C. Increase in blood pressure: Methylergonovine can increase blood pressure as a side effect. While monitoring blood pressure is important, an increase does not necessarily indicate that the medication is effective in achieving its primary goal of uterine contraction. Effectiveness is better assessed by the firmness of the fundus.
In summary, a firm fundus to palpation is the best indicator that Methylergonovine is effectively stimulating uterine contractions and managing postpartum hemorrhage.